P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P20309 |
ACM3_HUMAN |
Asthma [ICD-11: CA23] |
P20309 |
ACM3_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P20309 |
ACM3_HUMAN |
Functional bladder disorder [ICD-11: GC50] |
P20309 |
ACM3_HUMAN |
Glaucoma [ICD-11: 9C61] |
P20309 |
ACM3_HUMAN |
Nausea/vomiting [ICD-11: MD90] |
P20309 |
ACM3_HUMAN |
Peptic ulcer [ICD-11: DA61] |
P20309 |
ACM3_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P20309 |
ACM3_HUMAN |
Sebaceous gland disorder [ICD-11: ED91] |
P20309 |
ACM3_HUMAN |
Sjogren syndrome [ICD-11: 4A43] |
P20309 |
ACM3_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
P20309 |
ACM3_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P20309 |
ACM3_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P08173 |
ACM4_HUMAN |
Asthma [ICD-11: CA23] |
P08173 |
ACM4_HUMAN |
Eye anterior segment structural developmental anomaly [ICD-11: LA11] |
P08173 |
ACM4_HUMAN |
Glaucoma [ICD-11: 9C61] |
P08173 |
ACM4_HUMAN |
Nausea/vomiting [ICD-11: MD90] |
P08173 |
ACM4_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P08173 |
ACM4_HUMAN |
Attention deficit hyperactivity disorder [ICD-11: 6A05] |
P08912 |
ACM5_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P08912 |
ACM5_HUMAN |
Anterior uveitis [ICD-11: 9A96] |
P08912 |
ACM5_HUMAN |
Appearance/behaviour symptom [ICD-11: MB23] |
P08912 |
ACM5_HUMAN |
Asthma [ICD-11: CA23] |
P08912 |
ACM5_HUMAN |
Brain disease [ICD-11: 8C70-8E61] |
P08912 |
ACM5_HUMAN |
Central and peripheral nervous disease [ICD-11: 8A04-8E7Z] |
P08912 |
ACM5_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P08912 |
ACM5_HUMAN |
Cognition symptoms/signs/clinical sympton [ICD-11: MB21] |
P08912 |
ACM5_HUMAN |
Cough [ICD-11: MD12] |
P08912 |
ACM5_HUMAN |
Digestive system disease [ICD-11: DE2Z] |
P08912 |
ACM5_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P08912 |
ACM5_HUMAN |
Functional bladder disorder [ICD-11: GC50] |
P08912 |
ACM5_HUMAN |
Gastritis [ICD-11: DA42] |
P08912 |
ACM5_HUMAN |
General examination [ICD-11: QA00] |
P08912 |
ACM5_HUMAN |
Glaucoma [ICD-11: 9C61] |
P08912 |
ACM5_HUMAN |
Hypertension [ICD-11: BA00-BA04] |
P08912 |
ACM5_HUMAN |
Infectious gastroenteritis/colitis [ICD-11: 1A40] |
P08912 |
ACM5_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
P08912 |
ACM5_HUMAN |
Nystagmus [ICD-11: 9C84] |
P08912 |
ACM5_HUMAN |
Oesophagus motility disorder [ICD-11: DA21] |
P08912 |
ACM5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P08912 |
ACM5_HUMAN |
Pancreatitis [ICD-11: DC31-DC34] |
P08912 |
ACM5_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P08912 |
ACM5_HUMAN |
Peptic ulcer [ICD-11: DA61] |
P08912 |
ACM5_HUMAN |
Polyuria [ICD-11: MF55] |
P08912 |
ACM5_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
P08912 |
ACM5_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P08912 |
ACM5_HUMAN |
Urgency [ICD-11: N.A.] |
P08912 |
ACM5_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08912 |
ACM5_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P08912 |
ACM5_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P08912 |
ACM5_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P08912 |
ACM5_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P08912 |
ACM5_HUMAN |
Gastric ulcer [ICD-11: DA60] |
P08912 |
ACM5_HUMAN |
Attention deficit hyperactivity disorder [ICD-11: 6A05] |
P08912 |
ACM5_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P08912 |
ACM5_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P08912 |
ACM5_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q8TDU6 |
GPBAR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 |
GPBAR_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 |
GPBAR_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q14973 |
NTCP_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q14973 |
NTCP_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q14973 |
NTCP_HUMAN |
Gallbladder/bile ducts/liver structural developmental anomaly [ICD-11: LB20] |
Q14973 |
NTCP_HUMAN |
Inborn porphyrin/heme metabolism error [ICD-11: 5C58] |
P29317 |
EPHA2_HUMAN |
Brain cancer [ICD-11: 2A00] |
P29317 |
EPHA2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |